Skip to main content

15.05.2024 | Case Report

Spontaneous reactivation of hepatitis B virus with multiple novel mutations in an elderly patient with resolved hepatitis B virus infection

verfasst von: Tokio Sasaki, Keisuke Kakisaka, Akio Miyasaka, Masao Nishiya, Naoki Yanagawa, Hidekatsu Kuroda, Takayuki Matsumoto, Masaharu Takahashi, Hiroaki Okamoto

Erschienen in: Clinical Journal of Gastroenterology

Einloggen, um Zugang zu erhalten

Abstract

Spontaneous reactivation of the Hepatitis B virus (HBV) is rare in individuals with previously resolved infections. This report presents the case of a 71 year-old Japanese woman who experienced HBV reactivation without any prior immunosuppressive therapy or chemotherapy. Before the onset of liver injury, the patient was negative for hepatitis B surface antigen (HBsAg) but positive for hepatitis B surface antibody. She subsequently developed liver injury, with the reappearance of HBsAg and HBV DNA. The patient was successfully treated with tenofovir alafenamide, and prednisolone. Full-genome sequencing of HBV revealed subgenotype B1 without hepatitis B e-negative mutations in the precore and core promoter regions and 12 amino acid alterations in the pre-S1/S, P, and X genes. Notably, the S gene mutations D144A and K160N, which alter the antigenicity of HBsAg and potentially contribute to its reactivation, were identified. This case emphasizes the importance of vigilance for spontaneous reactivation of resolved HBV, highlighting the need for comprehensive genomic analysis to understand the associated virological intricacies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Collaborators GBDHB. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7:796–829.CrossRef Collaborators GBDHB. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7:796–829.CrossRef
2.
Zurück zum Zitat Seto WK, Lo YR, Pawlotsky JM, et al. Chronic hepatitis B virus infection. Lancet. 2018;392:2313–24.CrossRefPubMed Seto WK, Lo YR, Pawlotsky JM, et al. Chronic hepatitis B virus infection. Lancet. 2018;392:2313–24.CrossRefPubMed
3.
Zurück zum Zitat Smalls DJ, Kiger RE, Norris LB, et al. Hepatitis B Virus reactivation: risk factors and current management strategies. Pharmacotherapy. 2019;39:1190–203.CrossRefPubMedPubMedCentral Smalls DJ, Kiger RE, Norris LB, et al. Hepatitis B Virus reactivation: risk factors and current management strategies. Pharmacotherapy. 2019;39:1190–203.CrossRefPubMedPubMedCentral
5.
6.
Zurück zum Zitat Knoll A, Boehm S, Hahn J, et al. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transpl. 2004;33:925–9.CrossRef Knoll A, Boehm S, Hahn J, et al. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transpl. 2004;33:925–9.CrossRef
7.
Zurück zum Zitat Marusawa H, Imoto S, Ueda Y, et al. Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen. J Gastroenterol. 2001;36:633–6.CrossRefPubMed Marusawa H, Imoto S, Ueda Y, et al. Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen. J Gastroenterol. 2001;36:633–6.CrossRefPubMed
8.
Zurück zum Zitat Tong MJ, Sampliner RE, Govindarajan S, et al. Spontaneous reactivation of hepatitis B in Chinese patients with HBsAg-positive chronic active hepatitis. Hepatology. 1987;7:713–8.CrossRefPubMed Tong MJ, Sampliner RE, Govindarajan S, et al. Spontaneous reactivation of hepatitis B in Chinese patients with HBsAg-positive chronic active hepatitis. Hepatology. 1987;7:713–8.CrossRefPubMed
9.
Zurück zum Zitat Obara N, Inoue J, Endo H, et al. Spontaneous reactivation of hepatitis B virus with S gene mutations in an elderly patient with diabetic nephropathy. Clin J Gastroenterol. 2020;13:914–9.CrossRefPubMed Obara N, Inoue J, Endo H, et al. Spontaneous reactivation of hepatitis B virus with S gene mutations in an elderly patient with diabetic nephropathy. Clin J Gastroenterol. 2020;13:914–9.CrossRefPubMed
10.
Zurück zum Zitat Takakusagi S, Takagi H, Yokoyama Y, et al. Spontaneous reactivation of hepatitis B virus with a frameshift mutation in the precore region in an elderly hepatitis B virus carrier with lifestyle-related diseases. Clin J Gastroenterol. 2021;14:1202–10.CrossRefPubMed Takakusagi S, Takagi H, Yokoyama Y, et al. Spontaneous reactivation of hepatitis B virus with a frameshift mutation in the precore region in an elderly hepatitis B virus carrier with lifestyle-related diseases. Clin J Gastroenterol. 2021;14:1202–10.CrossRefPubMed
11.
Zurück zum Zitat Kamitsukasa H, Iri M, Tanaka A, et al. Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection. J Med Virol. 2015;87:589–600.CrossRefPubMed Kamitsukasa H, Iri M, Tanaka A, et al. Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection. J Med Virol. 2015;87:589–600.CrossRefPubMed
12.
Zurück zum Zitat Kim DH, Kim SB. Hepatic failure by spontaneous reactivation of hepatitis B Virus without a trigger factor in a patient with anti-HBs. Case Rep Gastroenterol. 2018;12:286–91.CrossRefPubMedPubMedCentral Kim DH, Kim SB. Hepatic failure by spontaneous reactivation of hepatitis B Virus without a trigger factor in a patient with anti-HBs. Case Rep Gastroenterol. 2018;12:286–91.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Mulyanto Depamede SN, Surayah K, et al. Identification and characterization of novel hepatitis B virus subgenotype C10 in Nusa Tenggara. Indonesia Arch Virol. 2010;155:705–15.CrossRefPubMed Mulyanto Depamede SN, Surayah K, et al. Identification and characterization of novel hepatitis B virus subgenotype C10 in Nusa Tenggara. Indonesia Arch Virol. 2010;155:705–15.CrossRefPubMed
14.
Zurück zum Zitat Usuda S, Tsuda F, Gotanda T, et al. A solid-phase enzyme immunoassay for the common and subtypic determinants of hepatitis B surface antigen with monoclonal antibodies. J Immunol Methods. 1986;87:203–10.CrossRefPubMed Usuda S, Tsuda F, Gotanda T, et al. A solid-phase enzyme immunoassay for the common and subtypic determinants of hepatitis B surface antigen with monoclonal antibodies. J Immunol Methods. 1986;87:203–10.CrossRefPubMed
15.
Zurück zum Zitat Ohnuma H, Takai E, Machida A, et al. Synthetic oligopeptides bearing a common or subtypic determinant of hepatitis B surface antigen. J Immunol. 1990;145:2265–71.CrossRefPubMed Ohnuma H, Takai E, Machida A, et al. Synthetic oligopeptides bearing a common or subtypic determinant of hepatitis B surface antigen. J Immunol. 1990;145:2265–71.CrossRefPubMed
16.
Zurück zum Zitat Okamoto H, Omi S, Wang Y, et al. The loss of subtypic determinants in alleles, d/y or w/r, on hepatitis B surface antigen. Mol Immunol. 1989;26:197–205.CrossRefPubMed Okamoto H, Omi S, Wang Y, et al. The loss of subtypic determinants in alleles, d/y or w/r, on hepatitis B surface antigen. Mol Immunol. 1989;26:197–205.CrossRefPubMed
17.
Zurück zum Zitat Beran A, Mhanna M, Haghbin H, et al. A case of hepatitis B virus reactivation triggered by acute Epstein-Barr virus infection. Cureus. 2021;3: e18676. Beran A, Mhanna M, Haghbin H, et al. A case of hepatitis B virus reactivation triggered by acute Epstein-Barr virus infection. Cureus. 2021;3: e18676.
18.
Zurück zum Zitat Pei R, Grund S, Verheyen J, et al. Spontaneous reactivation of hepatitis B virus replication in an HIV coinfected patient with isolated anti-hepatitis B core antibodies. Virol J. 2014;11:9.CrossRefPubMedPubMedCentral Pei R, Grund S, Verheyen J, et al. Spontaneous reactivation of hepatitis B virus replication in an HIV coinfected patient with isolated anti-hepatitis B core antibodies. Virol J. 2014;11:9.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Sagnelli C, Montella L, Grimaldi P, et al. COVID-19 as another trigger for HBV Reactivation: clinical case and review of literature. Pathogens. 2022;11:816.CrossRefPubMedPubMedCentral Sagnelli C, Montella L, Grimaldi P, et al. COVID-19 as another trigger for HBV Reactivation: clinical case and review of literature. Pathogens. 2022;11:816.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Michalak TI, Pasquinelli C, Guilhot S, et al. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 1994;93:230–9.CrossRefPubMedPubMedCentral Michalak TI, Pasquinelli C, Guilhot S, et al. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 1994;93:230–9.CrossRefPubMedPubMedCentral
21.
22.
Zurück zum Zitat Sakamoto K, Umemura T, Ito K, et al. Virological factors associated with the occurrence of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection analyzed through ultradeep sequencing. J Infect Dis. 2020;221:400–7.PubMed Sakamoto K, Umemura T, Ito K, et al. Virological factors associated with the occurrence of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection analyzed through ultradeep sequencing. J Infect Dis. 2020;221:400–7.PubMed
23.
Zurück zum Zitat Kramvis A, Arakawa K, Yu MC, et al. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol. 2008;80:27–46.CrossRefPubMed Kramvis A, Arakawa K, Yu MC, et al. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol. 2008;80:27–46.CrossRefPubMed
24.
Zurück zum Zitat Lazarevic I, Banko A, Miljanovic D, et al. Immune-escape hepatitis B virus mutations associated with viral reactivation upon immunosuppression. Viruses. 2019;11:778.CrossRefPubMedPubMedCentral Lazarevic I, Banko A, Miljanovic D, et al. Immune-escape hepatitis B virus mutations associated with viral reactivation upon immunosuppression. Viruses. 2019;11:778.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Lada O, Benhamou Y, Poynard T, et al. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of “a” determinant variants. J Virol. 2006;80:2968–75.CrossRefPubMedPubMedCentral Lada O, Benhamou Y, Poynard T, et al. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of “a” determinant variants. J Virol. 2006;80:2968–75.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Wang J, Zhu B, Lu M, et al. Hepatitis B virus preS/S gene mutations and their clinical implications. Annals Blood. 2017;2:17.CrossRef Wang J, Zhu B, Lu M, et al. Hepatitis B virus preS/S gene mutations and their clinical implications. Annals Blood. 2017;2:17.CrossRef
29.
Zurück zum Zitat Wu C, Zhang X, Tian Y, et al. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication. J Gen Virol. 2010;91:483–92.CrossRefPubMed Wu C, Zhang X, Tian Y, et al. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication. J Gen Virol. 2010;91:483–92.CrossRefPubMed
30.
Zurück zum Zitat Inoue J, Nakamura T, Masamune A. Roles of hepatitis B virus mutations in the viral reactivation after immunosuppression therapies. Viruses. 2019;11:457.CrossRefPubMedPubMedCentral Inoue J, Nakamura T, Masamune A. Roles of hepatitis B virus mutations in the viral reactivation after immunosuppression therapies. Viruses. 2019;11:457.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Oon C, Lim G, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine. 1995;13:699–702.CrossRefPubMed Oon C, Lim G, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine. 1995;13:699–702.CrossRefPubMed
Metadaten
Titel
Spontaneous reactivation of hepatitis B virus with multiple novel mutations in an elderly patient with resolved hepatitis B virus infection
verfasst von
Tokio Sasaki
Keisuke Kakisaka
Akio Miyasaka
Masao Nishiya
Naoki Yanagawa
Hidekatsu Kuroda
Takayuki Matsumoto
Masaharu Takahashi
Hiroaki Okamoto
Publikationsdatum
15.05.2024
Verlag
Springer Nature Singapore
Erschienen in
Clinical Journal of Gastroenterology
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-024-01984-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.